Armistice Capital’s AMAG Pharmaceuticals AMAG Stock Holding History

Armistice Capital’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,120,000	Closed	-$38.7M	–	134
2020 Q3	$38.7M	Hold	4,120,000	–	–	1.4%	21
2020 Q2	$31.5M	Hold	4,120,000	–	–	1.38%	25
2020 Q1	$25.5M	Buy	4,120,000 +60,000	+1%	+$529K	1.57%	22
2019 Q4	$49.4M	Hold	4,060,000	–	–	2.85%	4
2019 Q3	$46.9M	Buy	4,060,000 +260,000	+7%	+$2.74M	3.11%	7
2019 Q2	$38M	Buy	3,800,000 +484,000	+15%	+$5.22M	2.39%	11
2019 Q1	$42.7M	Buy	3,316,000 +1,438,000	+77%	+$21.4M	2.34%	8
2018 Q4	$28.5M	Sell	1,878,000 -202,000	-10%	-$3.85M	2.16%	12
2018 Q3	$41.6M	Hold	2,080,000	–	–	2.5%	11
2018 Q2	$40.6M	Buy	2,080,000 +176,000	+9%	+$3.89M	2.65%	10
2018 Q1	$38.4M	Buy	+1,904,000	New	+$32.2M	2.93%	6

Armistice Capital's AMAG Position: Q4 2020 in Review

Armistice Capital sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 4,120,000 shares — an estimated $38.7M sold.

Armistice Capital first reported a position in AMAG in Q1 2018 and held it in 11 quarters. The position peaked at $49.4M in Q4 2019. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

Armistice Capital reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Armistice Capital sold 4,120,000 AMAG Pharmaceuticals shares in Q4 2020, an estimated $38.7M.
Armistice Capital first reported a position in AMAG Pharmaceuticals in Q1 2018 and held it in 11 quarters.
Armistice Capital's AMAG Pharmaceuticals position peaked at $49.4M in Q4 2019.
1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on Armistice Capital's 13F filing for Q4 2020, filed 16 Feb 2021.